Matthew S Davids

42PUBLICATIONS
248CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)Cellular immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Mar 26, 2026
A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformation.

Jennifer L Crombie, Christine E Ryan, Yue Ren

|Jan 08, 2026
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia.

Kadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson

|Jan 08, 2026
First-line treatment for CLL in the era of targeted therapy.

Matthew S Davids, Stephan Stilgenbauer, Constantine S Tam

|Dec 29, 2025
Multiple Myeloma and Secondary Immunodeficiency: A Retrospective Database Analysis Assessing Burden of Infection and Treatment Patterns.

Csaba Siffel, Matthew S Davids, Colin Anderson-Smits

|Dec 05, 2025
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.

Ye Zhang, Lydie Debaize, Adam Langenbucher

|Dec 02, 2025
Clinical Outcomes in Patients With CLL Treated With BTKi at a Large US Cancer Center.

Kevin H Lin, Lynn Huynh, Xiaoqin Yang

Pageof 7

Frequent Collaborators

9 joint publications

Jennifer R Brown

7 joint publications

Christine E Ryan

6 joint publications

Svitlana Tyekucheva

5 joint publications

Erin Parry